
The Eye Care Support Pathway
The Eye Care Support Pathway is a new framework to ensure patients have timely access to information, advice and support throughout their eye care journey.
Search results
The Eye Care Support Pathway is a new framework to ensure patients have timely access to information, advice and support throughout their eye care journey.
Experience the thrill of the Reading Half Marathon, one of the UK’s most celebrated half marathons since its launch in 1983 and support Retina UK in 2025.
Biotechnology company Kiora Pharmaceuticals has been given the go-ahead to start in-human testing of a novel “small molecule” treatment, known as KIO-301, for advanced vision loss in retinitis pigmentosa (RP). The phase 1b clinical trial will take place in Adelaide, Australia, and will begin enrolling participants towards the end of 2022.